An additional benefit from cholecalciferol in this population was the reduction in albuminuria even in patients with diabetic nephropathy 25,44; this is likely due to the intervention of pathways dependent or independent of blocking the renin-angiotensin-aldosterone system 45. Here, REN is linked to diabetic kidney disease.